Nanoflex Robotics raises €10.8M Series A round
9 February 2023· Zurich, Switzerland· health, robotics, medical_devices, ai, b2b, software_hardware
The funding will be used to bring its first-generation robotic platform to market, accelerate the development of new neuro-interventional products, and drive first-in-human trials and regulatory clearance (FDA submission planned for Q3 2023).
Investors
LeadAscend Capital Partners
Also participating
Mountain LabsKinled Holding
About Nanoflex Robotics
Stage
Series A
Headquarters
Zurich, Switzerland
Founded
2021
Team Size
21–50
Sectors
healthroboticsmedical_devicesaib2bsoftware_hardware
Source: https://nanoflexrobotics.com/news/nanoflex-robotics-secures-over-usd12m-in-funding-support